Safety of verteporfin for treatment of subfoveal choroidal neovascular membranes associated with age-related macular degeneration

Author： Gaynes Bruce I   Fiscella Richard G  

Publisher： Informa Healthcare

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.3, Iss.4, 2004-07, pp. : 345-361

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pegaptanib sodium for the treatment of neovascular age-related macular degeneration

By Moshfeghi Andrew A   Puliafito Carmen A  

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 5, 2005-05 ,pp. : 671-682

Informa Healthcare

Access to resources Recommend Favorite

VEGF inhibitors for the treatment of neovascular age-related macular degeneration

By Barakat Mark Rami   Kaiser PK  

Expert Opinion on Investigational Drugs, Vol. 18, Iss. 5, 2009-05 ,pp. : 637-646

Informa Healthcare

Access to resources Recommend Favorite

An update on the pharmacotherapy of neovascular age-related macular degeneration

By Freund K Bailey   Mrejen Sarah   Gallego-Pinazo Roberto  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 8, 2013-06 ,pp. : 1017-1028

Informa Healthcare

Access to resources Recommend Favorite

Neovascular Age-Related Macular Degeneration: Potential Therapies

By Chappelow Aimee V.   Kaiser Peter K.  

Drugs, Vol. 68, Iss. 8, 2008-01 ,pp. : 1029-1036

Adis International

Access to resources Recommend Favorite

Anti-VEGF Compounds in the Treatment of Neovascular Age Related Macular Degeneration

By  

Current Drug Targets, Vol. 12, Iss. 2, 2011-01 ,pp. : 173-181

Bentham Science Publishers

Access to resources Recommend Favorite